Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 31 (PPIAP31) is a human pseudogene related to peptidylprolyl isomerase A (PPIA, cyclophilin A)[6][1]. Pseudogenes are DNA segments similar to functional genes but typically lack protein-coding ability due to disabling mutations[4]. Most pseudogenes do not encode active proteins but may sometimes have regulatory functions at the RNA level, such as acting as microRNA decoys or competitive endogenous RNAs in rare cases[2][4]. There is currently no evidence that PPIAP31 is involved in any specific biological function, disease, or therapeutic target activity.\n\nNote: PPIAP31 is distinct from PPIA, the functional protein involved in inflammation, apoptosis, cell signaling, and as a target of immunosuppressant cyclosporine[3][7]. If seeking information about a therapeutic target, refer to \"Peptidylprolyl isomerase A\" (PPIA/Cyclophilin A)[3][7].
Not applicable (no known mechanism of action for drugs acting on PPIAP31)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 31 (PPIAP31).